Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
Not yet recruiting · NCT07013279 · Registry updated 2025-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines | Glabellar Lines | Not yet recruiting | Phase 3 | 2025-06-10 | NCT07013279 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Daewoong Pharmaceutical Co. LTD. | 38 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chung-Ang University Hosptial | Seoul | South Korea | 3 |